Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397) |
---|
08/03/2005 | CN1213045C Tyrosine kinase inhibitors |
08/03/2005 | CN1213038C Benzophenones as inhibitors of reverse transcriptase |
08/03/2005 | CN1213035C 2,4-diamino-1,3,5-triazine, method for the production and use of the same as herbicides and plant growth regulators |
08/03/2005 | CN1213031C Method for producing 5-aryl nicotinaldehydes |
08/03/2005 | CN1213026C Carboxylic acids and carboxylic acid isosteres of N-heterocyclic compounds |
08/02/2005 | US6924376 Compounds, compositions and methods |
08/02/2005 | US6924330 Thioimidazolidine derivatives as light stabilizers for polymers |
08/02/2005 | US6924302 Nitrogen compounds such as 5-amino-3-[[4-(aminosulfonyl)phenyl]amino]-N-(2,6-difluorophenyl)-1H-1,2,4-triazole-1-carbothioamide, used as cyclin dependent and tyrosine kinase inhibitors, for prophylaxis of tumors |
08/02/2005 | US6924297 Naphathalene derivatives which bind to the EP4 receptor |
08/02/2005 | US6924290 Antitumor agents; anticancer agents; sexual disorders; cardiovascular disorders |
08/02/2005 | US6924287 Respiratory syncytial virus replication inhibitors |
08/02/2005 | US6924285 Bicyclic heterocyclic compounds, pharmaceutical compositions containing these compounds, their use and process for preparing them |
08/02/2005 | US6924284 PARP inhibitors |
08/02/2005 | US6924281 2-phenyl-1-[4-(2-aminoethoxy)-benzyl]-indoles as estrogenic agents |
08/02/2005 | US6924278 Heterocyclic carboxy amines such as (2R)-1-[3,5-Bis(trifluoromethyl)benzoyl]-4-[4-((3S)-3-ethylmorpholino)-2-butynyl]-2-[(1H-indol-3-yl)methyl]piperazine, used as substance P and neurokinin antagonist for prophylaxis of diseases |
08/02/2005 | US6924276 Diacid-substituted heteroaryl derivatives as matrix metalloproteinase inhibitors |
08/02/2005 | CA2332538C Novel 4-phenylpiperidines for the treatment of pruritic dermatoses |
08/02/2005 | CA2325358C 7-¬(4'-trifluoromethyl-biphenyl-2-carbonyl)amino|-quinoline-3-carboxylic acid amides, and methods of inhibiting the secretion of apolipoprotein b |
08/02/2005 | CA2243199C Novel 3,4-diaryl thiophenes and analogs thereof having use as antiinflammatory agents |
08/02/2005 | CA2132537C Basic derivatives of glutamic acid and aspartic acid as gastrin or cholecystokinin antagonists |
07/28/2005 | WO2005068468A2 Heterocyclic protein kinase inhibitors and uses thereof |
07/28/2005 | WO2005068448A1 Sulfonamides antagonising n-type calcium channels |
07/28/2005 | WO2005068437A1 2, 4 - diaminopyrimidines and their use for inducing cardiomyogenesis |
07/28/2005 | WO2005068436A1 6-amino-5-cyano-pyrimidine-4-ones used for improving perception, power of concentration, learning efficiency, and/or memory power |
07/28/2005 | WO2005067933A1 1-benzyl-5-piperazin-1-yl-3,4 dihydro-1h-quinazolin-2-one derivatives and the respective 1h-benzo(1,2,6)thiadiazine-2,2-dioxide and 1,4-dihydro-benzo(d) (1,3)oxazin-2-one derivatives as modulators of the 5-hydroxytryptamine receptor (5-ht) for the treatment of diseases of the central nervous system |
07/28/2005 | WO2005067923A1 Indole derivatives and use thereof as kinase inhibitors in particular ikk2 inhibitors |
07/28/2005 | WO2005067502A2 Alkylamino, arylamino, and sulfonamido cyclopentyl amide modulators of chemokine receptor activity |
07/28/2005 | WO2005048948A3 Urea derivatives as kinase modulators |
07/28/2005 | WO2005033330A3 Fluorescent probes for use in protein kinase inhibitor binding assay |
07/28/2005 | WO2002096905A8 Thiazole compounds useful as inhibitors of protein kinases |
07/28/2005 | US20050165242 hydrolysis of atorvastatin lactone with sodium hydroxide to form atorvastatin sodium salt solution; addition to an aqueous calcium chloride or calcium acetate solution; andisolation by filtration and drying; scalable, cost-effective and robust process |
07/28/2005 | US20050165074 inhibitors of protein tyrosine kinases, for preventing of cancer, cardiovascular disease, inflammation or multiple sclerosis |
07/28/2005 | US20050165063 Amine compounds and use thereof |
07/28/2005 | US20050165058 Oxybenzamide derivatives useful for inhibiting factor Xa or Vlla |
07/28/2005 | US20050165053 Substituted4-aryl-3-(3-aryl-1-oxo-2-propenyl)-2(1h)-quinolinones and analogs as activators of caspases and inducers of apoptosis and the use thereof |
07/28/2005 | US20050165052 combining substituted quinolines with a carrier; leishmania/HIV infection; viricide, parasiticide |
07/28/2005 | US20050165051 Taxanes having a C7 carbonate substituent |
07/28/2005 | US20050165050 Quinoline and isoquinoline derivatives, a process for their production and their use as inflammation inhibitors |
07/28/2005 | US20050165049 2-(2,2,2-Trifluoro-ethyl)-1,2,3,4-tetrahydro-isoquinoline-6-carboxylic acid quinolin-7-ylamides; treatment of acute, inflammatory and neuropathic pain, dental pain, general headache, migraine, cluster headache, mixed-vascular and non-vascular syndromes, arthritis, gastrointestinal disorders |
07/28/2005 | US20050165046 Bis-bicyclic amides and derivatives thereof and compositions containing them for the treatment of acute, inflammatory and neuropathic pain; 4-chloro-N-(2,3-dihydro-1,4-benzodioxin-6-yl)-7-(trifluoromethyl)-3-quinolinecarboxamide |
07/28/2005 | US20050165042 Fused tricyclic heterocycles useful for treating hyper-proliferative disoroders |
07/28/2005 | US20050165036 Substituted benzofurans and benzothiophenes, methods of making and methods of use as integrin antagonists |
07/28/2005 | US20050165031 1-(4-(3-(Pyridin-4-yl)propoxy)phenyl)-3-(5-tert-butylisoxazol-3-yl)urea; inhibits protein tyrosine kinases or a specific kinase or kinase class; for for treating and preventing conditions and diseases such as cancer, hematologic malignancies, cardiovascular disease, inflammation or multiple sclerosis |
07/28/2005 | US20050165028 e.g. 4-bromo-N-(2,3-dihydro-1,4-benzodioxin-6-yl)benzamide; analgesics, neuropathic pain, inflammation, arthritis, rheumatic diseases, inflammatory bowel disorders, eye disorders, or bladder disorders, psoriasis, wounds, burns, allergic skin, herpes simplex |
07/28/2005 | US20050165024 Urea derivatives as kinase modulators |
07/28/2005 | US20050165022 Dihydro-1,3,5-triazine amine derivatives and their therapeutic uses |
07/28/2005 | US20050165021 Polycyclic aryl and heteroaryl substituted 4-pyrones useful for selective inhibition of the coagulation cascade |
07/28/2005 | US20050165018 Such as N-(2-benzotriazolyl)-N'-(4-(1-(1H-imidazol-1-yl)-2-ethylbutyl)phenyl) -thiourea; for treatment of cellular proliferation/differentiation disorders; keratinization; oncology; dermatology |
07/28/2005 | US20050165016 Piperazinyl-, piperidinyl- and morpholinyl-derivatives as novel inhibitors of histone deacetylase |
07/28/2005 | US20050165007 Benzimidazoles and analogs thereof as antivirals |
07/28/2005 | US20050165003 Treating Alzheimer's Disease; 4-Chloro-N-(4-hydroxy-3-methoxy-benzyl)-N-(2-oxo-azepan-3-yl)-benzenesulfonamide for example; gamma secretase inhibitors; inhibition of beta-amyloid synthesis with minimal inhibition of Notch Signaling |
07/28/2005 | US20050165001 Quinazolinone and benzoxazinone derivatives and uses thereof |
07/28/2005 | US20050164885 Alkyl dihalogenated phenyl-substituted ketoenols useful as pesticides and herbicides |
07/28/2005 | US20050164868 Non-heating clay composites for building materials |
07/28/2005 | US20050163715 Dynamic organ function monitoring agents |
07/28/2005 | CA2553200A1 6-amino-5-cyano-pyrimidine-4-ones used for improving perception, power of concentration, learning efficiency, and/or memory power |
07/28/2005 | CA2552953A1 Indole derivatives and use thereof as kinase inhibitors in particular ikk2 inhibitors |
07/28/2005 | CA2552681A1 1-benzyl-5-piperazin-1-yl-3,4 dihydro-1h-quinazolin-2-one derivatives and the respective 1h-benzo(1,2,6)thiadiazine-2,2-dioxide and 1,4-dihydro-benzo(d) (1,3)oxazin-2-one derivatives as modulators of the 5-hydroxytryptamine receptor (5-ht) for the treatment of diseases of the central nervous system |
07/28/2005 | CA2551869A1 Alkylamino, arylamino, and sulfonamido cyclopentyl amide modulators of chemokine receptor activity |
07/28/2005 | CA2551770A1 2, 4 - diaminopyrimidines and their use for inducing cardiomyogenesis |
07/28/2005 | CA2547080A1 Heterocyclic protein kinase inhibitors and uses thereof |
07/28/2005 | CA2456430A1 Improved process for the preparation of amorphous atorvastatin calcium |
07/27/2005 | EP1557414A1 Isoquinoline compounds and medicinal use thereof |
07/27/2005 | EP1557411A1 N-phenyl-(2r,5s)dimethylpiperadine derivative |
07/27/2005 | EP1557410A2 Bacterial gyrase inhibitors and uses thereof |
07/27/2005 | EP1556390A2 Functionalized ionic liquids, and methods of use thereof |
07/27/2005 | EP1556379A2 Chemical compounds |
07/27/2005 | EP1556376A1 Large conductance calcium-activated k channel opener |
07/27/2005 | EP1556375A2 Flavone derivatives as inhibitors of cyclin-dependent kinases |
07/27/2005 | EP1556374A2 Benzopyranone compounds, compositions thereof, and methods for treating or preventing cancer |
07/27/2005 | EP1556373A1 Cannabinoid receptor ligands and uses thereof |
07/27/2005 | EP1556369A1 Pyridazinone-derivatives as pde4 inhibitors |
07/27/2005 | EP1556362A2 Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
07/27/2005 | EP1556356A1 Tetrahydroquinoline derivatives as crth2 antagonists |
07/27/2005 | EP1556349A1 1,4-disubstituted piperidine derivatives and their use as 11-betahsd1 inhibitors |
07/27/2005 | EP1556348A1 Indolylalkylamino-methylidenecarbamate derivatives useful as gnrh antagonists |
07/27/2005 | EP1556347A2 Gamma lactams as prostaglandin agonists and use thereof |
07/27/2005 | EP1556346A1 1-phenylpyrrolidine-2-one-3-carboxamides |
07/27/2005 | EP1556055A2 Use of cyclic nucleotide phosphodiesterase inhibitors having a benzodiazepine structure in therapy |
07/27/2005 | EP1556052A2 Mitotic kinesin inhibitors |
07/27/2005 | EP1556049A1 Piperidine-pyridazones and phthalazones as pde4 inhibitors |
07/27/2005 | EP1556047A2 Pgd2 receptor antagonists for the treatment of inflammatory diseases |
07/27/2005 | EP1556035A2 Novel aromatic compounds possessing antifungal or antibacterial activity |
07/27/2005 | EP1379523B1 1,2,3,4-tetrahydroisoquinolines derivatives as urotensin ii receptor antagonists |
07/27/2005 | EP1318992B1 Imidazole derivatives as raf kinase inhibitors |
07/27/2005 | EP1250335B1 Process and intermediates for the preparation of imidazopyridines |
07/27/2005 | EP1133489B1 Isonipecotamides for the treatment of integrin-mediated disorders |
07/27/2005 | EP0973705B1 Chromatographic enantiomer separation of lactones |
07/27/2005 | CN1646540A Functionalized ionic liquids, and methods of use thereof |
07/27/2005 | CN1646524A Benzopyran derivatives substituted with secondary amines including tetrazole, method for the preparation thereof and pharmaceutical compositions containing them |
07/27/2005 | CN1646520A 1, 3, 5-triazine derivatives as ligands for human adenosine-A3 receptors |
07/27/2005 | CN1646516A Imidazolinylmethyl aralkylsulfonamides |
07/27/2005 | CN1646499A Fused pyridazine derivative compounds and drugs containing the compounds as the active ingredient |
07/27/2005 | CN1646497A New aryl imidazoles and related compounds as C5a receptor modulators |
07/27/2005 | CN1646495A Amine compounds and use thereof |
07/27/2005 | CN1646490A Novel crystal forms of atorvastatin hemi-calcium and processes for their preparation, as well as novel processes for preparing atorvastatin hemi-calcium forms I, VIII and IX |
07/27/2005 | CN1646460A 2-(2, 6-dichlorophenyl)-diarylimidazoles |
07/27/2005 | CN1646446A Non-heating clay composites for building materials |
07/27/2005 | CN1646141A Modified nucleosides for treatment of viral infections and abnormal cellular proliferation |
07/26/2005 | US6921821 Antagonists of melanin concentrating hormone receptor |